{"schema_version":"secwatch.filing_event.v1","accession":"0001174947-24-000144","form_type":"8-K","ticker":"CNMD","cik":"0000816956","company_name":"CONMED Corp","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.995976+00:00","generated_at":"2026-06-06T14:22:00.002079+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"CONMED Q4 sales $327M (+30.4% YoY); adjusted EPS $1.06 (+152%); guides FY24 rev $1.34-1.365B","bullets":["Q4 sales $327.0M, +30.4% YoY (31.5% constant currency); domestic +33.3%, intl +26.5% as reported.","Q4 GAAP diluted EPS $1.05; adjusted diluted EPS $1.06, up 152.4% vs Q4 2022.","FY2023 sales $1,244.7M (+19.1%); GAAP EPS $2.04 vs loss of $2.68; adjusted EPS $3.45 (+30.2%).","FY2024 revenue guidance $1.340B-$1.365B (8-10% growth); adjusted EPS guidance $4.30-$4.40 (25-28% growth).","Record revenue achieved in both Q4 and full year; balanced growth across General Surgery and Orthopedics."],"urls":{"canonical":"https://secwatch.observer/filing/0001174947-24-000144","json":"https://secwatch.observer/filing/0001174947-24-000144.json","markdown":"https://secwatch.observer/filing/0001174947-24-000144.md","text":"https://secwatch.observer/filing/0001174947-24-000144.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/816956/000117494724000144/0001174947-24-000144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/816956/000117494724000144/form8k-31428_cnmd.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T14:22:00.002079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"db3fd8eb41e239c242bc3737dc79491650199146","claim":"CONMED Corp reported financial results for the fourth quarter and full-year ended December 31, 2023.","evidence_excerpt":"On January 31, 2024, CONMED Corporation issued a press release announcing financial results for the fourth quarter ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/816956/000117494724000144/0001174947-24-000144-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full-year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}